You are here

Clinical Trials: Brain Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Sunday, February 26, 2017 - 20:00
Condition:   Cerebral Palsy
Intervention:   Biological: Matched sibling donor cord blood cell infusion
Sponsors:   Murdoch Childrens Research Institute;   The Royal Children's Hospital Melbourne;   Children's Health Queensland;   Monash Health;   Sydney Children's Network;   Cerebral Palsy Alliance
Recruiting - verified March 2017
Posted: Tuesday, December 13, 2016 - 20:00
Condition:   Autoimmune Encephalopathy
Intervention:   Drug: Vigabatrin 500 MG
Sponsor:   Seoul National University Hospital
Recruiting - verified December 2016
Posted: Sunday, October 2, 2016 - 19:00
Condition:   Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions:   Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
Sponsor:   Liaocheng People's Hospital
Recruiting - verified October 2016
Posted: Friday, September 9, 2016 - 19:00
Condition:   Epilepsy
Intervention:   Drug: Omega-3
Sponsor:   Seoul National University Hospital
Recruiting - verified September 2016
Posted: Friday, September 2, 2016 - 19:00
Condition:   Alzheimer's Disease
Interventions:   Biological: CB-AC-02;   Biological: Placebo
Sponsor:   CHABiotech CO., Ltd
Not yet recruiting - verified September 2016
Posted: Wednesday, August 24, 2016 - 19:00
Condition:   Neonatal Hypoxic-ischaemic Encephalopathy
Intervention:   Drug: autologous cord blood stem cell
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Posted: Wednesday, July 6, 2016 - 19:00
Condition:   Stroke
Interventions:   Other: Adipose Derived Stem Cells;   Other: Vehicle media
Sponsors:   University Hospital, Grenoble;   European Commission H2020 program;   Univ Grenoble Alpes, France;   Servicio Madrileño de Salud, Madrid, Spain;   Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic;   Servicio Andaluz de Salud, Spain;   University of Glasgow;   University of Eastern Finland;   Etablissement Français du Sang;   University of Tampere;   Histocell SL, Spain;   Medfiles CRO, Finland;   Institut National de la Santé Et de la Recherche Médicale, France;   Hospices Civils de Lyon;   Association groupe ESSEC, France;   NOVADISCOVERY SAS, France;   FINOVATIS, France;   CHU Besancon, France;   Assistance Publique - Hôpitaux de Paris;   CHU Toulouse, France;   CHU Bordeaux, France;   CHU Cote de Nacre, Caen, France;   Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Servicio de Salud de Castilla La Mancha, Albacete, Spain;   Servizo Galego de Saude, Santiago de Compostela, Spain;   Pirkanmaa Hospital District, Tampere, Finland;   Hospital Vall d'Hebron;   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
Posted: Monday, June 27, 2016 - 19:00
Condition:   Agitation in Dementia, Including Alzheimer's Disease
Interventions:   Drug: ITI-007;   Drug: Placebo
Sponsor:   Intra-Cellular Therapies, Inc.
Recruiting - verified June 2016
Posted: Monday, June 20, 2016 - 19:00
Condition:   Alzheimer Dementia
Interventions:   Drug: Human Mesenchymal Stem Cells and Lactated Riunger's Solution;   Other: Placebo
Sponsors:   Stemedica Cell Technologies, Inc.;   Stemedica International SA
Recruiting - verified July 2016
Posted: Friday, June 3, 2016 - 19:00
Condition:   Stroke
Intervention:   Drug: ADSCs
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting - verified June 2016

Pages